玻片染色剂市场－全球产业规模、份额、趋势、机会、预测：依产品、技术、最终用户、地区和竞争格局划分，2021-2031年

全球玻片染色设备市场预计将从 2025 年的 48.7 亿美元成长到 2031 年的 66.9 亿美元，复合年增长率为 5.43%。

玻片染色系统是一种自动化实验室仪器，用于对玻璃载玻片上的细胞和组织样本进行染色，从而提高显微镜观察和疾病诊断的对比。市场成长的主要驱动力是全球慢性病（包括癌症）发生率上升导致切片检查检测量显着增加。此外，为减少人为错误、提高工作流程效率以及解决熟练组织病理学家严重短缺的问题，实验室自动化需求的不断增长也是推动市场成长的因素之一。

另一方面，这些设备的购买和维护成本高昂，常常为发展中地区的小规模实验室和医疗机构的预算带来沉重负担，阻碍了市场成长。例如，美国癌症协会报告称，预计到2024年，美国新增癌症病例数将首次超过200万例，显示市场需求正在增加。病例数的增加凸显了对高通量染色解决方案的迫切需求，以维持及时、准确的诊断流程。

市场驱动因素

慢性疾病和感染疾病率的上升是全球玻片染色设备市场的主要驱动力，从根本上增加了准确诊断所需的组织分析量。随着癌症等疾病在全球的流行，临床检查室必须应对复杂的切片检查样本工作量，这些样本需要严格的染色才能进行显微镜检查。诊断需求的激增需要能够快速、稳定地处理大量玻片的高通量染色系统，从而缩短关键患者报告的周转时间。根据《采血针》 2025年9月的一项调查，预计到2050年，全球癌症病例将超过3000万例，比2024年增长60%。这种情况凸显了先进自动化染色设备的紧迫性，这些设备能够在不影响品质的前提下保持高日处理能力。

同时，熟练的组织病理学家和技术人员严重短缺，加速了检查室自动化技术的应用，并正在改变市场模式。为了应对劳动力短缺问题，自动化切片染色系统正在逐步推广，消除人工操作的差异，使有限的人员能够专注于高价值的诊断工作。根据英国英国病理学院2025年6月发布的报告，78%的受访病理学家表示「目前的员工数量不足以满足日益增长的临床需求」。因此，检查室正在整合数位病理工具和自动化系统，以建立无缝的工作流程。例如，徕卡生物系统公司于2025年1月宣布对Indica Labs进行策略性投资，以加速人工智慧驱动的伴随诊断技术的发展，显示整个产业正向完全整合的自动化解决方案转型。

市场挑战

自动化玻片染色系统高昂的购置和维修成本对小规模检查室和医疗机构构成了显着的进入门槛，严重限制了市场成长。这些机构通常资金储备有限，难以承担先进染色平台所需的大量前期投资。因此，许多机构被迫延长老旧设备的使用寿命，或继续依赖人工操作，这直接降低了新设备的销售周转率，并限制了製造商的潜在市场规模。

这种财务压力迫使决策者优先考虑必要的营运支出而非资本投资，导致技术应用停滞不前。资产管理策略调整也反映了这种限制的严重性。根据美国医院协会 (AHA) 2025 年的一项调查，94% 的医疗机构管理者预计会推迟设备升级以应对财务负担。由于预算限製而对新技术投资的犹豫，直接阻碍了医疗产业充分利用诊断自动化日益增长的需求。

市场趋势

多重染色技术的引入正在从根本上改变市场格局，它能够同时检测单一组织切片上的多种生物标记物，突破了传统单标记物免疫组化技术的局限性。这项技术在肿瘤免疫学领域的重要性日益凸显，因为了解肿瘤微环境中免疫细胞复杂的空间分布对于制定有效的治疗方案至关重要。与仅以速度为导向的标准高通量仪器不同，这些先进平台能够最大限度地从有限的切片检查组织中获取数据，从而实现更深入的表型分析。太空生物学系统的日益普及清楚地反映了这项技术的商业性势头。根据Akoya Biosciences公司统计，截至2024年11月，全球太空分析系统的安装量已达1,299套，年成长15%，凸显了该产业正迅速向高度复杂的染色技术转型。

同时，伴随诊断染色通讯协定的扩展正在改变整个行业，製药公司越来越多地将标靶治疗与特定的自动化染色检测相结合。这一趋势需要开发封闭式染色设备，以确保严格的监管合规性和检测的可重复性，而这两点对于精准医疗中的患者分层至关重要。随着伴随必要诊断检测的新药获得核准，检查室不得不投资这些专用平台，以维持其临床意义并确保获得报销。这种整合的经济影响显着，并在许多经济挑战中推动了成长。根据罗氏截至2025年1月的财年财务报告，诊断业务核心销售额增长了8%，这一业绩显然归功于对免疫诊断产品和用于精准诊断的先进染色解决方案的需求不断增长。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球玻片染色剂市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品组成（试剂（染色剂、封片剂、组织固定剂、处理剂）、设备）
  • 依技术（H&E染色、ISH、IHC、血液学、细胞学）
  • 依最终使用者（医院/诊所、学术/研究机构、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美玻片染色剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲玻片染色剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区载玻片染料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲玻片染色剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美玻片染色剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球玻片染色剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific inc.
• F. Hoffmann-La Roche AG
• Danaher Corporation
• Merck KGaA
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Abcam plc.
• Siemens Healthineers
• General Data Company, Inc.
• Biocare Medical, LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Slide Stainers Market is projected to expand from USD 4.87 Billion in 2025 to USD 6.69 Billion by 2031, registering a CAGR of 5.43%. Slide stainers are automated laboratory instruments utilized to color cells or tissue samples on glass slides, thereby improving contrast for microscopic examination and disease diagnosis. The market is primarily propelled by the increasing global prevalence of chronic diseases, especially cancer, which creates a need for a significantly higher volume of biopsy tests. Furthermore, the sector is supported by a growing demand for laboratory automation to reduce manual errors, enhance workflow efficiency, and mitigate the severe shortage of skilled histopathologists.

Conversely, market growth is hindered by the substantial acquisition and upkeep costs of these instruments, which frequently burden the budgets of smaller laboratories and healthcare facilities in developing areas. To demonstrate the intensity of demand, the American Cancer Society reported that the projected number of new cancer cases in the United States surpassed 2 million for the first time in 2024. This rising caseload emphasizes the critical need for high-throughput staining solutions to maintain timely and precise diagnostic workflows.

Market Driver

The increasing incidence of chronic and infectious diseases acts as a major catalyst for the Global Slide Stainers Market, fundamentally boosting the volume of tissue analysis needed for accurate diagnosis. As the prevalence of conditions like cancer rises globally, clinical laboratories must manage a compounding workload of biopsy samples requiring rigorous staining for microscopic review. This surge in diagnostic demand requires high-throughput staining systems capable of processing large batches of slides quickly and consistently, thereby shortening turnaround times for essential patient reports. According to research from The Lancet in September 2025, global cancer cases are expected to exceed 30 million by 2050, a 60% increase from 2024 levels, highlighting the urgent need for advanced automated stainers that can sustain high daily throughputs without sacrificing quality.

Simultaneously, the accelerating adoption of laboratory automation is transforming the market landscape, largely due to acute shortages of skilled histopathologists and technicians. Automated slide stainers are increasingly deployed to address these workforce constraints, eliminating manual inconsistencies and allowing limited personnel to focus on higher-value diagnostic tasks. In a June 2025 report by the Royal College of Pathologists, 78% of surveyed pathologists stated that current staffing levels are insufficient to meet growing clinical demands. Consequently, laboratories are integrating these automated systems with digital pathology tools to create seamless workflows; for example, Leica Biosystems announced a strategic investment in Indica Labs in January 2025 to accelerate AI-enabled companion diagnostics, reflecting the industry's shift toward fully integrated automated solutions.

Market Challenge

The substantial acquisition and maintenance costs associated with automated slide stainers significantly restrict market growth by creating a high barrier to entry for smaller laboratories and healthcare facilities. These organizations often operate with limited capital reserves, making it difficult to justify the heavy upfront investment required for advanced staining platforms. Consequently, many facilities are forced to prolong the lifespan of legacy equipment or continue relying on manual processes, which directly reduces the turnover rate for new instrument sales and limits the total addressable market for manufacturers.

This financial pressure compels decision-makers to prioritize essential operational expenses over capital improvements, effectively stalling technological adoption. The severity of this constraint is evident in strategic adjustments regarding asset management; according to the American Hospital Association in 2025, 94% of healthcare administrators expected to delay equipment upgrades to manage financial strain. This hesitation to invest in new technology, driven by budgetary limitations, directly hampers the industry's ability to capitalize on the growing demand for diagnostic automation.

Market Trends

The adoption of multiplexing and multi-staining technologies is fundamentally shifting the market by enabling the simultaneous detection of multiple biomarkers on a single tissue slide, surpassing the limitations of traditional single-marker immunohistochemistry. This capability is becoming increasingly critical in immuno-oncology, where understanding the complex spatial arrangement of immune cells within the tumor microenvironment is essential for effective treatment planning. Unlike standard high-throughput units designed solely for speed, these advanced platforms allow laboratories to maximize data yield from limited biopsy tissue, facilitating deeper phenotypic analysis. The growing commercial traction of this technology is evident in the rising deployment of spatial biology systems; according to Akoya Biosciences in November 2024, its global installed base of spatial instruments reached 1,299 units, a 15% increase compared to the prior year, highlighting the sector's rapid pivot toward high-complexity staining.

In parallel, the expansion of companion diagnostic staining protocols is reshaping the industry as pharmaceutical companies increasingly pair targeted therapies with specific automated staining assays. This trend necessitates the development of closed-system stainers that ensure strict regulatory compliance and assay reproducibility, which are non-negotiable for patient stratification in precision medicine. As new drugs are approved with mandatory diagnostic tests, laboratories are compelled to invest in these specialized platforms to maintain clinical relevance and ensure reimbursement. The economic impact of this integration is significant, driving growth even amidst broader economic challenges; according to Roche's January 2025 financial report, the Diagnostics Division achieved an 8% growth in its base business sales, a performance explicitly attributed to the heightened demand for immunodiagnostic products and advanced staining solutions used in precision diagnostics.

Key Market Players

• Thermo Fisher Scientific inc.
• F. Hoffmann-La Roche AG
• Danaher Corporation
• Merck KGaA
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Abcam plc.
• Siemens Healthineers
• General Data Company, Inc.
• Biocare Medical, LLC

Report Scope

In this report, the Global Slide Stainers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Slide Stainers Market, By Product

• Reagent (Stains, Mounting, Tissue Fixation, Processing)
• Equipment

Slide Stainers Market, By Technique

• H&E
• ISH
• IHC
• Hematology
• Cytology

Slide Stainers Market, By End user

• Hospitals & Clinics
• Academic & Research Institutes
• Others

Slide Stainers Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Slide Stainers Market.

Available Customizations:

Global Slide Stainers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Slide Stainers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagent (Stains, Mounting, Tissue Fixation, Processing), Equipment)
  • 5.2.2. By Technique (H&E, ISH, IHC, Hematology, Cytology)
  • 5.2.3. By End user (Hospitals & Clinics, Academic & Research Institutes, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Slide Stainers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Slide Stainers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Slide Stainers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Slide Stainers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End user

7. Europe Slide Stainers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Slide Stainers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End user
  • 7.3.2. France Slide Stainers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Slide Stainers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Slide Stainers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Slide Stainers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End user

8. Asia Pacific Slide Stainers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Slide Stainers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End user
  • 8.3.2. India Slide Stainers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Slide Stainers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Slide Stainers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Slide Stainers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End user

9. Middle East & Africa Slide Stainers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Slide Stainers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Slide Stainers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Slide Stainers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End user

10. South America Slide Stainers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Slide Stainers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Slide Stainers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Slide Stainers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Slide Stainers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. F. Hoffmann-La Roche AG
• 15.3. Danaher Corporation
• 15.4. Merck KGaA
• 15.5. Agilent Technologies, Inc.
• 15.6. Becton, Dickinson and Company
• 15.7. Abcam plc.
• 15.8. Siemens Healthineers
• 15.9. General Data Company, Inc.
• 15.10. Biocare Medical, LLC

16. Strategic Recommendations

17. About Us & Disclaimer